Form 8-K - Current report:
SEC Accession No. 0001628280-23-006039
Filing Date
2023-03-02
Accepted
2023-03-02 16:03:32
Documents
15
Period of Report
2023-03-02
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20230302.htm   iXBRL 8-K 34134
2 EX-99.1 ardx-20221231xexhibit991.htm EX-99.1 96525
6 ardx-20230302_g1.jpg GRAPHIC 2570
7 image_0.jpg GRAPHIC 2381
  Complete submission text file 0001628280-23-006039.txt   293272

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20230302.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20230302_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20230302_pre.xml EX-101.PRE 13044
9 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20230302_htm.xml XML 11233
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 23698790
SIC: 2834 Pharmaceutical Preparations